Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-03-19
Pages: 106 Pages
Report ld: 4677461
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Hemostats Market Size(US$)
CAGR 2025-2031
5.9%
Market Size,2031
USD 4,570
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 3,240 million
Market Forecast in 2031(Value)
US$ 4,570 million
CAGR
5.9%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Hemostats market size was US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Global Hemostats key players include Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard, The Medicines Company, etc. Global top five manufacturers hold a share over 55%.
North America is the largest market, with a share about 35%, followed by China, and Europe, both have a share over 35 percent.
In terms of product, Thrombin-Based Hemostats is the largest segment, with a share over 40%. And in terms of application, the largest application is Hospital Treatment, followed by Prehospital Treatment, etc.
The global Hemostats market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
By Company
- Ethicon
- Pfizer
- Baxter International Inc.
- C. R. Bard
- The Medicines Company
- Anika Therapeutics
- Advanced Medical Solutions
- Integra LifeSciences Corporation
- B Braun Melsungen AG
- Gelita Medical GmbH
- Equimedical
- Vascular Solutions
- Marine Polymer Technologies
- Z-Medica, LLC
- CryoLife
- BioCer Entwicklungs-GmbH.
- Biom'Up SAS
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Thrombin-Based Hemostats
- Oxidized Regenerated Cellulose Based Hemostats
- Combination Hemostats
- Gelatin Based Hemostats
- Collagen Based Hemostats
Segment by Application
- Prehospital Treatment
- Hospital Treatment
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Hemostats market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Oxidized Regenerated Cellulose Based Hemostats in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Hospital Treatment in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Hemostats value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Hemostats Product Scope
1.2 Hemostats by Type
1.2.1 Global Hemostats Sales by Type (2020 & 2024 & 2031)
1.2.2 Thrombin-Based Hemostats
1.2.3 Oxidized Regenerated Cellulose Based Hemostats
1.2.4 Combination Hemostats
1.2.5 Gelatin Based Hemostats
1.2.6 Collagen Based Hemostats
1.3 Hemostats by Application
1.3.1 Global Hemostats Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Prehospital Treatment
1.3.3 Hospital Treatment
1.4 Global Hemostats Market Estimates and Forecasts (2020-2031)
1.4.1 Global Hemostats Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Hemostats Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Hemostats Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Hemostats Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Hemostats Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Hemostats Sales Market Share by Region (2020-2025)
2.2.2 Global Hemostats Revenue Market Share by Region (2020-2025)
2.3 Global Hemostats Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Hemostats Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Hemostats Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Hemostats Market Size and Prospective (2020-2031)
2.4.2 Europe Hemostats Market Size and Prospective (2020-2031)
2.4.3 China Hemostats Market Size and Prospective (2020-2031)
2.4.4 Japan Hemostats Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Hemostats Historic Market Review by Type (2020-2025)
3.1.1 Global Hemostats Sales by Type (2020-2025)
3.1.2 Global Hemostats Revenue by Type (2020-2025)
3.1.3 Global Hemostats Price by Type (2020-2025)
3.2 Global Hemostats Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Hemostats Sales Forecast by Type (2026-2031)
3.2.2 Global Hemostats Revenue Forecast by Type (2026-2031)
3.2.3 Global Hemostats Price Forecast by Type (2026-2031)
3.3 Different Types Hemostats Representative Players
4 Global Market Size by Application
4.1 Global Hemostats Historic Market Review by Application (2020-2025)
4.1.1 Global Hemostats Sales by Application (2020-2025)
4.1.2 Global Hemostats Revenue by Application (2020-2025)
4.1.3 Global Hemostats Price by Application (2020-2025)
4.2 Global Hemostats Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Hemostats Sales Forecast by Application (2026-2031)
4.2.2 Global Hemostats Revenue Forecast by Application (2026-2031)
4.2.3 Global Hemostats Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Hemostats Application
5 Competition Landscape by Players
5.1 Global Hemostats Sales by Players (2020-2025)
5.2 Global Top Hemostats Players by Revenue (2020-2025)
5.3 Global Hemostats Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostats as of 2024)
5.4 Global Hemostats Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Hemostats, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Hemostats, Product Type & Application
5.7 Global Key Manufacturers of Hemostats, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Hemostats Sales by Company
6.1.1.1 North America Hemostats Sales by Company (2020-2025)
6.1.1.2 North America Hemostats Revenue by Company (2020-2025)
6.1.2 North America Hemostats Sales Breakdown by Type (2020-2025)
6.1.3 North America Hemostats Sales Breakdown by Application (2020-2025)
6.1.4 North America Hemostats Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Hemostats Sales by Company
6.2.1.1 Europe Hemostats Sales by Company (2020-2025)
6.2.1.2 Europe Hemostats Revenue by Company (2020-2025)
6.2.2 Europe Hemostats Sales Breakdown by Type (2020-2025)
6.2.3 Europe Hemostats Sales Breakdown by Application (2020-2025)
6.2.4 Europe Hemostats Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Hemostats Sales by Company
6.3.1.1 China Hemostats Sales by Company (2020-2025)
6.3.1.2 China Hemostats Revenue by Company (2020-2025)
6.3.2 China Hemostats Sales Breakdown by Type (2020-2025)
6.3.3 China Hemostats Sales Breakdown by Application (2020-2025)
6.3.4 China Hemostats Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Hemostats Sales by Company
6.4.1.1 Japan Hemostats Sales by Company (2020-2025)
6.4.1.2 Japan Hemostats Revenue by Company (2020-2025)
6.4.2 Japan Hemostats Sales Breakdown by Type (2020-2025)
6.4.3 Japan Hemostats Sales Breakdown by Application (2020-2025)
6.4.4 Japan Hemostats Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Ethicon
7.1.1 Ethicon Company Information
7.1.2 Ethicon Business Overview
7.1.3 Ethicon Hemostats Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Ethicon Hemostats Products Offered
7.1.5 Ethicon Recent Development
7.2 Pfizer
7.2.1 Pfizer Company Information
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Hemostats Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Pfizer Hemostats Products Offered
7.2.5 Pfizer Recent Development
7.3 Baxter International Inc.
7.3.1 Baxter International Inc. Company Information
7.3.2 Baxter International Inc. Business Overview
7.3.3 Baxter International Inc. Hemostats Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Baxter International Inc. Hemostats Products Offered
7.3.5 Baxter International Inc. Recent Development
7.4 C. R. Bard
7.4.1 C. R. Bard Company Information
7.4.2 C. R. Bard Business Overview
7.4.3 C. R. Bard Hemostats Sales, Revenue and Gross Margin (2020-2025)
7.4.4 C. R. Bard Hemostats Products Offered
7.4.5 C. R. Bard Recent Development
7.5 The Medicines Company
7.5.1 The Medicines Company Company Information
7.5.2 The Medicines Company Business Overview
7.5.3 The Medicines Company Hemostats Sales, Revenue and Gross Margin (2020-2025)
7.5.4 The Medicines Company Hemostats Products Offered
7.5.5 The Medicines Company Recent Development
7.6 Anika Therapeutics
7.6.1 Anika Therapeutics Company Information
7.6.2 Anika Therapeutics Business Overview
7.6.3 Anika Therapeutics Hemostats Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Anika Therapeutics Hemostats Products Offered
7.6.5 Anika Therapeutics Recent Development
7.7 Advanced Medical Solutions
7.7.1 Advanced Medical Solutions Company Information
7.7.2 Advanced Medical Solutions Business Overview
7.7.3 Advanced Medical Solutions Hemostats Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Advanced Medical Solutions Hemostats Products Offered
7.7.5 Advanced Medical Solutions Recent Development
7.8 Integra LifeSciences Corporation
7.8.1 Integra LifeSciences Corporation Company Information
7.8.2 Integra LifeSciences Corporation Business Overview
7.8.3 Integra LifeSciences Corporation Hemostats Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Integra LifeSciences Corporation Hemostats Products Offered
7.8.5 Integra LifeSciences Corporation Recent Development
7.9 B Braun Melsungen AG
7.9.1 B Braun Melsungen AG Company Information
7.9.2 B Braun Melsungen AG Business Overview
7.9.3 B Braun Melsungen AG Hemostats Sales, Revenue and Gross Margin (2020-2025)
7.9.4 B Braun Melsungen AG Hemostats Products Offered
7.9.5 B Braun Melsungen AG Recent Development
7.10 Gelita Medical GmbH
7.10.1 Gelita Medical GmbH Company Information
7.10.2 Gelita Medical GmbH Business Overview
7.10.3 Gelita Medical GmbH Hemostats Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Gelita Medical GmbH Hemostats Products Offered
7.10.5 Gelita Medical GmbH Recent Development
7.11 Equimedical
7.11.1 Equimedical Company Information
7.11.2 Equimedical Business Overview
7.11.3 Equimedical Hemostats Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Equimedical Hemostats Products Offered
7.11.5 Equimedical Recent Development
7.12 Vascular Solutions
7.12.1 Vascular Solutions Company Information
7.12.2 Vascular Solutions Business Overview
7.12.3 Vascular Solutions Hemostats Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Vascular Solutions Hemostats Products Offered
7.12.5 Vascular Solutions Recent Development
7.13 Marine Polymer Technologies
7.13.1 Marine Polymer Technologies Company Information
7.13.2 Marine Polymer Technologies Business Overview
7.13.3 Marine Polymer Technologies Hemostats Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Marine Polymer Technologies Hemostats Products Offered
7.13.5 Marine Polymer Technologies Recent Development
7.14 Z-Medica, LLC
7.14.1 Z-Medica, LLC Company Information
7.14.2 Z-Medica, LLC Business Overview
7.14.3 Z-Medica, LLC Hemostats Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Z-Medica, LLC Hemostats Products Offered
7.14.5 Z-Medica, LLC Recent Development
7.15 CryoLife
7.15.1 CryoLife Company Information
7.15.2 CryoLife Business Overview
7.15.3 CryoLife Hemostats Sales, Revenue and Gross Margin (2020-2025)
7.15.4 CryoLife Hemostats Products Offered
7.15.5 CryoLife Recent Development
7.16 BioCer Entwicklungs-GmbH.
7.16.1 BioCer Entwicklungs-GmbH. Company Information
7.16.2 BioCer Entwicklungs-GmbH. Business Overview
7.16.3 BioCer Entwicklungs-GmbH. Hemostats Sales, Revenue and Gross Margin (2020-2025)
7.16.4 BioCer Entwicklungs-GmbH. Hemostats Products Offered
7.16.5 BioCer Entwicklungs-GmbH. Recent Development
7.17 Biom'Up SAS
7.17.1 Biom'Up SAS Company Information
7.17.2 Biom'Up SAS Business Overview
7.17.3 Biom'Up SAS Hemostats Sales, Revenue and Gross Margin (2020-2025)
7.17.4 Biom'Up SAS Hemostats Products Offered
7.17.5 Biom'Up SAS Recent Development
8 Hemostats Manufacturing Cost Analysis
8.1 Hemostats Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Hemostats
8.4 Hemostats Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Hemostats Distributors List
9.3 Hemostats Customers
10 Hemostats Market Dynamics
10.1 Hemostats Industry Trends
10.2 Hemostats Market Drivers
10.3 Hemostats Market Challenges
10.4 Hemostats Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Hemostats Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Hemostats Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Hemostats Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Hemostats Sales (K Pcs) by Region (2020-2025)
Table 5. Global Hemostats Sales Market Share by Region (2020-2025)
Table 6. Global Hemostats Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Hemostats Revenue Share by Region (2020-2025)
Table 8. Global Hemostats Sales (K Pcs) Forecast by Region (2026-2031)
Table 9. Global Hemostats Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Hemostats Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Hemostats Revenue Share Forecast by Region (2026-2031)
Table 12. Global Hemostats Sales by Type (K Pcs) & (2020-2025)
Table 13. Global Hemostats Sales Share by Type (2020-2025)
Table 14. Global Hemostats Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Hemostats Price by Type (USD/Pcs) & (2020-2025)
Table 16. Global Hemostats Sales by Type (K Pcs) & (2026-2031)
Table 17. Global Hemostats Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Hemostats Price by Type (USD/Pcs) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Hemostats Sales by Application (K Pcs) & (2020-2025)
Table 21. Global Hemostats Sales Share by Application (2020-2025)
Table 22. Global Hemostats Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Hemostats Price by Application (USD/Pcs) & (2020-2025)
Table 24. Global Hemostats Sales by Application (K Pcs) & (2026-2031)
Table 25. Global Hemostats Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Hemostats Price by Application (USD/Pcs) & (2026-2031)
Table 27. New Sources of Growth in Hemostats Application
Table 28. Global Hemostats Sales by Company (K Pcs) & (2020-2025)
Table 29. Global Hemostats Sales Share by Company (2020-2025)
Table 30. Global Hemostats Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Hemostats Revenue Share by Company (2020-2025)
Table 32. Global Hemostats by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostats as of 2024)
Table 33. Global Market Hemostats Average Price by Company (USD/Pcs) & (2020-2025)
Table 34. Global Key Manufacturers of Hemostats, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Hemostats, Product Type & Application
Table 36. Global Key Manufacturers of Hemostats, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Hemostats Sales by Company (2020-2025) & (K Pcs)
Table 39. North America Hemostats Sales Market Share by Company (2020-2025)
Table 40. North America Hemostats Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Hemostats Revenue Market Share by Company (2020-2025)
Table 42. North America Hemostats Sales by Type (2020-2025) & (K Pcs)
Table 43. North America Hemostats Sales Market Share by Type (2020-2025)
Table 44. North America Hemostats Sales by Application (2020-2025) & (K Pcs)
Table 45. North America Hemostats Sales Market Share by Application (2020-2025)
Table 46. Europe Hemostats Sales by Company (2020-2025) & (K Pcs)
Table 47. Europe Hemostats Sales Market Share by Company (2020-2025)
Table 48. Europe Hemostats Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Hemostats Revenue Market Share by Company (2020-2025)
Table 50. Europe Hemostats Sales by Type (2020-2025) & (K Pcs)
Table 51. Europe Hemostats Sales Market Share by Type (2020-2025)
Table 52. Europe Hemostats Sales by Application (2020-2025) & (K Pcs)
Table 53. Europe Hemostats Sales Market Share by Application (2020-2025)
Table 54. China Hemostats Sales by Company (2020-2025) & (K Pcs)
Table 55. China Hemostats Sales Market Share by Company (2020-2025)
Table 56. China Hemostats Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Hemostats Revenue Market Share by Company (2020-2025)
Table 58. China Hemostats Sales by Type (2020-2025) & (K Pcs)
Table 59. China Hemostats Sales Market Share by Type (2020-2025)
Table 60. China Hemostats Sales by Application (2020-2025) & (K Pcs)
Table 61. China Hemostats Sales Market Share by Application (2020-2025)
Table 62. Japan Hemostats Sales by Company (2020-2025) & (K Pcs)
Table 63. Japan Hemostats Sales Market Share by Company (2020-2025)
Table 64. Japan Hemostats Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Hemostats Revenue Market Share by Company (2020-2025)
Table 66. Japan Hemostats Sales by Type (2020-2025) & (K Pcs)
Table 67. Japan Hemostats Sales Market Share by Type (2020-2025)
Table 68. Japan Hemostats Sales by Application (2020-2025) & (K Pcs)
Table 69. Japan Hemostats Sales Market Share by Application (2020-2025)
Table 70. Ethicon Company Information
Table 71. Ethicon Description and Business Overview
Table 72. Ethicon Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Ethicon Hemostats Product
Table 74. Ethicon Recent Development
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Pfizer Hemostats Product
Table 79. Pfizer Recent Development
Table 80. Baxter International Inc. Company Information
Table 81. Baxter International Inc. Description and Business Overview
Table 82. Baxter International Inc. Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Baxter International Inc. Hemostats Product
Table 84. Baxter International Inc. Recent Development
Table 85. C. R. Bard Company Information
Table 86. C. R. Bard Description and Business Overview
Table 87. C. R. Bard Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. C. R. Bard Hemostats Product
Table 89. C. R. Bard Recent Development
Table 90. The Medicines Company Company Information
Table 91. The Medicines Company Description and Business Overview
Table 92. The Medicines Company Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. The Medicines Company Hemostats Product
Table 94. The Medicines Company Recent Development
Table 95. Anika Therapeutics Company Information
Table 96. Anika Therapeutics Description and Business Overview
Table 97. Anika Therapeutics Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Anika Therapeutics Hemostats Product
Table 99. Anika Therapeutics Recent Development
Table 100. Advanced Medical Solutions Company Information
Table 101. Advanced Medical Solutions Description and Business Overview
Table 102. Advanced Medical Solutions Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Advanced Medical Solutions Hemostats Product
Table 104. Advanced Medical Solutions Recent Development
Table 105. Integra LifeSciences Corporation Company Information
Table 106. Integra LifeSciences Corporation Description and Business Overview
Table 107. Integra LifeSciences Corporation Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Integra LifeSciences Corporation Hemostats Product
Table 109. Integra LifeSciences Corporation Recent Development
Table 110. B Braun Melsungen AG Company Information
Table 111. B Braun Melsungen AG Description and Business Overview
Table 112. B Braun Melsungen AG Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. B Braun Melsungen AG Hemostats Product
Table 114. B Braun Melsungen AG Recent Development
Table 115. Gelita Medical GmbH Company Information
Table 116. Gelita Medical GmbH Description and Business Overview
Table 117. Gelita Medical GmbH Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Gelita Medical GmbH Hemostats Product
Table 119. Gelita Medical GmbH Recent Development
Table 120. Equimedical Company Information
Table 121. Equimedical Description and Business Overview
Table 122. Equimedical Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Equimedical Hemostats Product
Table 124. Equimedical Recent Development
Table 125. Vascular Solutions Company Information
Table 126. Vascular Solutions Description and Business Overview
Table 127. Vascular Solutions Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Vascular Solutions Hemostats Product
Table 129. Vascular Solutions Recent Development
Table 130. Marine Polymer Technologies Company Information
Table 131. Marine Polymer Technologies Description and Business Overview
Table 132. Marine Polymer Technologies Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Marine Polymer Technologies Hemostats Product
Table 134. Marine Polymer Technologies Recent Development
Table 135. Z-Medica, LLC Company Information
Table 136. Z-Medica, LLC Description and Business Overview
Table 137. Z-Medica, LLC Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. Z-Medica, LLC Hemostats Product
Table 139. Z-Medica, LLC Recent Development
Table 140. CryoLife Company Information
Table 141. CryoLife Description and Business Overview
Table 142. CryoLife Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 143. CryoLife Hemostats Product
Table 144. CryoLife Recent Development
Table 145. BioCer Entwicklungs-GmbH. Company Information
Table 146. BioCer Entwicklungs-GmbH. Description and Business Overview
Table 147. BioCer Entwicklungs-GmbH. Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 148. BioCer Entwicklungs-GmbH. Hemostats Product
Table 149. BioCer Entwicklungs-GmbH. Recent Development
Table 150. Biom'Up SAS Company Information
Table 151. Biom'Up SAS Description and Business Overview
Table 152. Biom'Up SAS Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 153. Biom'Up SAS Hemostats Product
Table 154. Biom'Up SAS Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Hemostats Distributors List
Table 158. Hemostats Customers List
Table 159. Hemostats Market Trends
Table 160. Hemostats Market Drivers
Table 161. Hemostats Market Challenges
Table 162. Hemostats Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemostats Product Picture
Figure 2. Global Hemostats Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Hemostats Sales Market Share by Type in 2024 & 2031
Figure 4. Thrombin-Based Hemostats Product Picture
Figure 5. Oxidized Regenerated Cellulose Based Hemostats Product Picture
Figure 6. Combination Hemostats Product Picture
Figure 7. Gelatin Based Hemostats Product Picture
Figure 8. Collagen Based Hemostats Product Picture
Figure 9. Global Hemostats Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 10. Global Hemostats Sales Market Share by Application in 2024 & 2031
Figure 11. Prehospital Treatment Examples
Figure 12. Hospital Treatment Examples
Figure 13. Global Hemostats Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Hemostats Sales Growth Rate (2020-2031) & (US$ Million)
Figure 15. Global Hemostats Sales (K Pcs) Growth Rate (2020-2031)
Figure 16. Global Hemostats Price Trends Growth Rate (2020-2031) & (USD/Pcs)
Figure 17. Hemostats Report Years Considered
Figure 18. Global Market Hemostats Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 19. Global Hemostats Revenue Market Share by Region: 2020 VS 2024
Figure 20. North America Hemostats Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. North America Hemostats Sales (K Pcs) Growth Rate (2020-2031)
Figure 22. Europe Hemostats Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. Europe Hemostats Sales (K Pcs) Growth Rate (2020-2031)
Figure 24. China Hemostats Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. China Hemostats Sales (K Pcs) Growth Rate (2020-2031)
Figure 26. Japan Hemostats Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. Japan Hemostats Sales (K Pcs) Growth Rate (2020-2031)
Figure 28. Global Hemostats Revenue Share by Type (2020-2025)
Figure 29. Global Hemostats Sales Share by Type (2026-2031)
Figure 30. Global Hemostats Revenue Share by Type (2026-2031)
Figure 31. Global Hemostats Revenue Share by Application (2020-2025)
Figure 32. Global Hemostats Revenue Growth Rate by Application in 2020 & 2024
Figure 33. Global Hemostats Sales Share by Application (2026-2031)
Figure 34. Global Hemostats Revenue Share by Application (2026-2031)
Figure 35. Global Hemostats Sales Share by Company (2024)
Figure 36. Global Hemostats Revenue Share by Company (2024)
Figure 37. Global 5 Largest Hemostats Players Market Share by Revenue in Hemostats: 2020 & 2024
Figure 38. Hemostats Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 39. Manufacturing Cost Structure of Hemostats
Figure 40. Manufacturing Process Analysis of Hemostats
Figure 41. Hemostats Industrial Chain
Figure 42. Channels of Distribution (Direct Vs Distribution)
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 5.9% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What is the annual compound growth rate of the global Hemostats market size from 2025 to 2031?
What was the global market size of Hemostats in 2025?
Which companies rank high in the global Hemostats market?
What was the global market size of Hemostats in 2031?
Related Reports
Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hemostats market is projected to grow from US$ 2239 million in 2025 to US$ 3316 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-08
Pages: 175
USD 4900.00
(Single User License)
Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemostats market size was US$ 2239 million in 2025 and is forecast to reach a readjusted size of US$ 3316 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published Date: 2026-03-08
Pages: 104
USD 4250.00
(Single User License)
Global Hemostats Market Research Report 2026
The global Hemostats market was valued at US$ 2239 million in 2025 and is anticipated to reach US$ 3316 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-03-08
Pages: 134
USD 2900.00
(Single User License)
Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemostats was estimated to be worth US$ 2239 million in 2025 and is projected to reach US$ 3316 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-03-08
Pages: 143
USD 3950.00
(Single User License)
Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemostats market is projected to grow from US$ 3076 million in 2024 to US$ 4570 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 173
USD 4900.00
(Single User License)
Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hemostats was estimated to be worth US$ 3076 million and is forecast to reach approximately US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 162
USD 5900.00
(Single User License)
Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemostats was estimated to be worth US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 150
USD 3950.00
(Single User License)
Global Hemostats Market Research Report 2025
The global market for Hemostats was valued at US$ 3076 million in the year 2024 and is projected to reach a revised size of US$ 4570 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published Date: 2025-01-16
Pages: 106
USD 2900.00
(Single User License)
Global Hemostats Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published Date: 2024-04-17
Pages: 182
USD 5600.00
(Single User License)
Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published Date: 2024-04-16
Pages: 160
USD 5900.00
(Single User License)
Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hemostats market is projected to grow from US$ 2239 million in 2025 to US$ 3316 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-08
Pages: 175
USD 4900.00 (Single User License)Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemostats market size was US$ 2239 million in 2025 and is forecast to reach a readjusted size of US$ 3316 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published: 2026-03-08
Pages: 104
USD 4250.00 (Single User License)Global Hemostats Market Research Report 2026
The global Hemostats market was valued at US$ 2239 million in 2025 and is anticipated to reach US$ 3316 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-03-08
Pages: 134
USD 2900.00 (Single User License)Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemostats was estimated to be worth US$ 2239 million in 2025 and is projected to reach US$ 3316 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-03-08
Pages: 143
USD 3950.00 (Single User License)Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemostats market is projected to grow from US$ 3076 million in 2024 to US$ 4570 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 173
USD 4900.00 (Single User License)Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hemostats was estimated to be worth US$ 3076 million and is forecast to reach approximately US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 162
USD 5900.00 (Single User License)Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemostats was estimated to be worth US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 150
USD 3950.00 (Single User License)Global Hemostats Market Research Report 2025
The global market for Hemostats was valued at US$ 3076 million in the year 2024 and is projected to reach a revised size of US$ 4570 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published: 2025-01-16
Pages: 106
USD 2900.00 (Single User License)Global Hemostats Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published: 2024-04-17
Pages: 182
USD 5600.00 (Single User License)Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published: 2024-04-16
Pages: 160
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now